BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27513756)

  • 1. Ingenol Mebutate 500 µg on the Cheekbones with Concomitant Conjunctivitis.
    Gaide O; Cattin V
    Dermatology; 2016; 232 Suppl 1():4-6. PubMed ID: 27513756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the use of ingenol mebutate to prevent non-melanoma skin cancer.
    Erlendsson AM
    Dan Med J; 2017 Nov; 64(11):. PubMed ID: 29115209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ingenol mebutate: a new option for actinic keratosis treatment.
    Gras J
    Drugs Today (Barc); 2013 Jan; 49(1):15-22. PubMed ID: 23362492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis.
    Berman B
    Expert Opin Drug Saf; 2015; 14(12):1969-78. PubMed ID: 26524598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The European Medicines Agency approval of ingenol mebutate (Picato) for the cutaneous treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults: summary of the scientific assessment of the Committee for Medicinal Products for Human Use (CHMP).
    Tzogani K; Nagercoil N; Hemmings RJ; Samir B; Gardette J; Demolis P; Salmonson T; Pignatti F
    Eur J Dermatol; 2014; 24(4):457-63. PubMed ID: 25115145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Histologic Evaluation of Ingenol Mebutate 0.015% Gel for the Cosmetic Improvement of Photoaged Skin.
    Handler MZ; Bloom BS; Goldberg DJ
    Dermatol Surg; 2018 Jan; 44(1):61-67. PubMed ID: 28858927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of ingenol mebutate gel for actinic keratosis in patients in a community dermatology practice.
    Bettencourt MS
    J Drugs Dermatol; 2014 Mar; 13(3):269-73. PubMed ID: 24595570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ingenol mebutate gel for actinic keratosis.
    Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
    N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rapidly growing squamous cell carcinoma after ingenol mebutate treatment].
    Ehret M; Velter C; Tebacher M; Bruant-Rodier C; Cribier B
    Ann Dermatol Venereol; 2018 Oct; 145(10):607-612. PubMed ID: 29779859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bullous reaction after application of a single dose ingenol mebutate].
    Salskov-Iversen ML; Lorentzen HF
    Ugeskr Laeger; 2013 Dec; 175(49A):V07130437. PubMed ID: 25353257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
    Berman B; Nestor MS; Newburger J; Park H; Swenson N
    J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Efficacy and Irritation of Ingenol Mebutate Gel 0.015% Used With or Without Dimethicone Lotion for Treatment of Actinic Keratosis on the Face.
    Jim On SC; Hashim PW; Nia JK; Lebwohl MG
    J Drugs Dermatol; 2017 May; 16(5):432-436. PubMed ID: 28628678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses.
    Lebwohl M; Shumack S; Stein Gold L; Melgaard A; Larsson T; Tyring SK
    JAMA Dermatol; 2013 Jun; 149(6):666-70. PubMed ID: 23553119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis.
    Stockfleth E; Bastian M
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):911-918. PubMed ID: 30074409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and side effects in patients with actinic keratosis treated with ingenol mebutate: a pilot study.
    Jubert-Esteve E; Del Pozo-Hernando LJ; Izquierdo-Herce N; Bauzá-Alonso A; Martín-Santiago A; Jones-Caballero M
    Actas Dermosifiliogr; 2015 Oct; 106(8):644-50. PubMed ID: 26130156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.
    Anderson L; Schmieder GJ; Werschler WP; Tschen EH; Ling MR; Stough DB; Katsamas J
    J Am Acad Dermatol; 2009 Jun; 60(6):934-43. PubMed ID: 19467365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of ingenol mebutate 0.015% gel after cryosurgery of actinic keratosis: 12-month results.
    Berman B; Goldenberg G; Hanke CW; Tyring SK; Werschler WP; Knudsen KM; Larsson T; Swanson N
    J Drugs Dermatol; 2014 Jun; 13(6):741-7. PubMed ID: 24918567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erosive pustular dermatosis of the scalp following topical ingenol mebutate for actinic keratoses.
    Vaccaro M; Borgia F; Gasco L; Cannavò SP
    Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28685901
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized, phase IIa exploratory trial to assess the safety and preliminary efficacy of LEO 43204 in patients with actinic keratosis.
    Sinnya S; Tan JM; Prow TW; Primiero C; McEniery E; Selmer J; Østerdal ML; Soyer HP
    Br J Dermatol; 2016 Feb; 174(2):305-11. PubMed ID: 26499175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response.
    Rosen RH; Gupta AK; Tyring SK
    J Am Acad Dermatol; 2012 Mar; 66(3):486-93. PubMed ID: 22055282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.